Search for: "In re: Abbott Laboratories"
Results 181 - 200
of 216
Sorted by Relevance
|
Sort by Date
2 Oct 2008, 12:36 pm
Abbott Laboratories, 447 F.3d 861, 867 (5th Cir. 2006), the court blew out this type of claim, finding the defendant's warning about high blood pressure sufficient and that there was no need to go further ant tell doctors about what high blood pressure itself can cause. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
9 Jan 2009, 7:00 am
Volkswagon-based transfer mandamus order in In re TS Tech USA (Inventive Step) (Hal Wegner) (EDTexweblog.com) (EDTexweblog.com) (Washington State Patent Law Blog) (Patently-O) (Law360) (Patent Prospector) ECJ decides Obelix too famous to be confused with MOBILIX mobile phone service: Les Éditions Albert René Sàrl v Office for Harmonisation in the Internal Market, Orange A/S (Class 46) (IPKat) Global Global – General Moral rights famous… [read post]
4 Apr 2008, 1:00 am
: (IPBiz) Pharma & Biotech - Products Abilify (Aripiprazole) – Otsuka files US patent infringement suit against Teva over seeking approval for generic Abilify: (IP Law360), Aricept (Donepezil) – US federal judge grants Eisai’s request for preliminary injunction blocking Teva from marketing generic version of Aricept: (IP Law360), (Orange Book Blog), Carbatrol (Carbamazepine) – US federal judge delivers mixed ruling in Shire… [read post]
6 May 2010, 4:12 pm
Abbott Laboratories, 397 F. [read post]
27 Jun 2008, 10:04 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
23 Dec 2007, 8:00 pm
You can separately subscribe to the IP Thinktank Global week in Review at [feeds.feedburner.com]GlobalEvents in Bali heap further pressure on all IP owners: (IAM),Velcro defies generic claim in domain name battle: (OUT-LAW),ICANN forms group to hasten non-English domain names: (IP Justice)WTO members continue debate on geographical indications register: (Intellectual Property Watch),Creative Commons launches CCo and CC programs: (World IP Day),Green IP Strategy - risks… [read post]
27 Oct 2011, 4:24 am
Depakote similarly was approved to treat seizures, not psychiatric conditions (except for acute mania in bipolar disorder), yet Abbott Laboratories allegedly marketed it “as a treatment for agitation, aggression in the elderly and other uses not approved by the Food and Drug Administration. [read post]
10 Jun 2010, 1:54 pm
And we’re right. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
21 Nov 2008, 1:36 pm
You can separately subscribe to the IP Think Tank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: USPTO releases ‘FY2008 Performance and Accountability Report’; claims success despite backlog (Managing Intellectual Property) (Law360) (Patent Librarian’s Notebook) (Patent Docs) (Peter Zura's 271 Patent Blog) (Patent Prospector) USPTO transition team appointed (Managing Intellectual Property) (Intellectual Property… [read post]
22 Mar 2008, 2:00 am
: (IPBiz),US: Two remaining challenged WARF embryonic stem cell patents upheld in ex parte reexamination: (Holman's Biotech IP Blog), Pharma & Biotech - ProductsAricept (Donepezil) – USV wins appeal against USPTO decision: (Spicy IP),Celerex (Celecoxib) – CAFC decision in Celebrex patents dispute between Pfizer and Teva will cut patent term by one and a half years: (Patent Baristas), Inersan – Ranbaxy in-licenses Inersan to CD Pharma to market in India and… [read post]
28 Mar 2008, 6:00 am
: (IAM)DSS case: Europe’s patent demise: (IPEG),EU calls on US to fulfill TRIPS obligations re copyright: (The IP Factor),How to safeguard unprotected know-how in FP7 projects: (IPR Helpdesk),European Council calls for a free movement of knowledge: (IPR-Helpdesk),Madrid amendments for double-treatied Union members: (IPKat),Proposed Europe-wide rules governing biometric passports are still unsatisfactory despite some concessions, according to European Data Protection Supervisor:… [read post]
25 Jun 2013, 1:27 pm
Abbott Laboratories, 201 F.3d 883 (7th Cir. 2000), didn’t apply because the survey wasn’t being used to define the meaning of that phrase. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]
30 Jul 2010, 4:06 am
Jackson v. [read post]
22 Nov 2023, 6:44 am
(I’m here; my Manne is here, and here with Lazar Radic; former FTC General Counsel Alden Abbott says that the FTC’s complaint is “Perhaps the Greatest Affront to Consumer and Producer Welfare in Antitrust History” here). [read post]
28 Oct 2011, 7:00 am
Abbott Laboratories, Inc., 259 F.3d 1226, 1235 (10th Cir. 2001) ([the prescribing nurse’s] “failure to read the label - a basic task which she was trained to perform - was an efficient intervening cause of [plaintiff’s] injury”) (applying Kansas law). [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro (Escitalopram)… [read post]
